NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Zynex, Inc. (OTCMKTS: ZYXIQ) (“Zynex” or the “Company”) inclusive on behalf of all persons and entities that purchased or otherwise acquired Zynex shares between February 25, 2021 and December 15, 2025, both dates inclusive (the "Class Period"). Investors have until April 21, 2026, to seek appointments as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUB ...

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Ostin Technology Group Co., Ltd. (NASDAQ: OST) (“Ostin” or the “Company”) inclusive on behalf of all persons and entities that purchased or otherwise acquired Ostin shares between May 11, 2025 and June 26, 2025, both dates inclusive (the "Class Period"). Investors have until April 17, 2026, to seek appointments as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CA ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Kyndryl Holdings, Inc. (NYSE: KD)  (“Kyndryl” or the “Company”) inclusive on behalf of all persons and entities that purchased or otherwise acquired Kyndryl shares August 7, 2024 and February 9, 2026, both dates inclusive (the "Class Period"). Investors have until April 13, 2026, to seek appointments as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMI ...

Group 1 - Choice Hotels International, Inc. experienced a data breach in January 2026, potentially compromising personal information of individuals, including names, Social Security numbers, and dates of birth [2][3] - Wolf Haldenstein Adler Freeman & Herz LLP is investigating claims on behalf of those affected by the data breach [1] - Affected individuals have been notified that their personal information may be for sale on the dark web [3] Group 2 - Wolf Haldenstein is recognized for its expertise in consumer rights litigation across various courts in the United States [5] - The firm has multiple offices in major cities, including New York, Chicago, Nashville, and San Diego [5] - The firm is actively seeking to assist individuals impacted by the data breach and has provided contact information for inquiries [4]

Core Viewpoint - A class action lawsuit has been filed against Picard Medical, Inc. for allegedly issuing false and misleading statements during a specific class period from September 2, 2025, to October 31, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities that purchased or acquired Picard shares during the class period [1] - Investors have until April 3, 2026, to seek appointments as lead plaintiff [1][2] Group 2: Allegations Against Picard Medical - The complaint alleges that Picard Medical was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [6] - Insiders and/or affiliates reportedly used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [6] - Picard's public statements and risk disclosures allegedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [6]

Core Viewpoint - A class action lawsuit has been filed against PomDoctor, Ltd. for allegedly making materially false and misleading statements during the class period from October 9, 2025, to December 11, 2025, affecting investors who purchased American Depositary Receipts [1][2] Group 1: Allegations - The complaint alleges that PomDoctor was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [6] - It is claimed that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [6] - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price, rendering their statements about business operations and prospects materially false and misleading [6] Group 2: Legal Process - Investors have until April 6, 2026, to seek appointments as lead plaintiff in the class action lawsuit [1][2] - The law firm Wolf Haldenstein Adler Freeman & Herz LLP, with over 125 years of experience in securities litigation, is leading the case and encourages affected investors to come forward [4]

Core Viewpoint - A class action lawsuit has been filed against China Liberal Education Holdings Ltd. for allegedly making materially false and misleading statements during the class period from January 22, 2025, to January 30, 2025, leading to significant investor losses [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities that purchased or acquired China Liberal securities during the specified class period [1]. - Investors have until March 31, 2026, to seek appointments as lead plaintiff in the case [2]. Group 2: Allegations Against the Company - The complaint alleges that individuals impersonating investment advisors on social media platforms fraudulently induced investors to purchase shares of China Liberal stock, which artificially inflated the stock price [6]. - On January 30, 2025, the price of China Liberal stock collapsed, resulting in significant losses for many investors [6]. - There are allegations that executives at China Liberal may have known about or participated in the fraudulent conduct, which raises questions about the accuracy of the company's statements regarding its business and operations [6].

NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers of Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or the “Company”) that a federal securities class action has been filed on behalf of investors who purchased Beyond Meat shares between February 27, 2025 and November 11, 2025, inclusive (the “Class Period”). Investors have until March 24, 2026, to seek appointments as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Alle ...

Core Viewpoint - A federal securities class action has been filed against BellRing Brands, Inc. for allegedly making materially false and misleading statements regarding its sales performance and demand trends during the specified class period [1][2]. Allegations - The complaint claims that BellRing and certain executives violated federal securities laws by failing to disclose that the company's strong reported sales were not due to increased consumer demand but rather due to customers accumulating excess inventory to mitigate earlier supply shortages [2][8]. - Following the easing of supply constraints, customers began to destock by selling through existing inventory and reducing new orders, which led to weakened underlying demand for BellRing products [8]. Corrective Disclosure - On August 4, 2025, BellRing announced its fiscal Q3 2025 financial results, significantly narrowing its full-year 2025 net sales outlook to a range of $2.28–$2.32 billion, which disappointed investors [2]. Stock Price Reaction - After the announcement on August 4, 2025, BellRing's stock price fell approximately $17.46 per share, or nearly 33%, dropping from $53.64 to $36.18 the following day [3]. Lead Plaintiff Deadline - Investors interested in being appointed as Lead Plaintiff must file a motion with the court by March 23, 2026 [4]. Legal Representation - Wolf Haldenstein Adler Freeman & Herz LLP, a law firm with over 125 years of experience in securities litigation, is representing the investors affected by the alleged misrepresentations [6].

Core Viewpoint - A federal securities class action has been filed against Agilon Health, Inc. for alleged securities fraud during the class period from February 6, 2025, to August 4, 2025, with a deadline for investors to seek lead plaintiff status by March 2, 2026 [1][2]. Group 1: Legal Action - The complaint alleges that Agilon and certain officers and/or directors engaged in securities fraud or other unlawful business practices [2]. - Investors who purchased Agilon shares during the specified class period are eligible to join the class action [1]. Group 2: Market Reaction - Following the announcements made on August 4, 2025, Agilon's stock price fell by $0.94 per share, representing a 51.52% decline, closing at $0.88 on August 5, 2025 [3]. Group 3: Company Leadership and Financial Update - Steven Sell has stepped down as President, CEO, and Board Director of Agilon [7]. - The company reported its Q2 2025 results, with the Executive Chair noting that industry headwinds were "more acute than previously expected" [7]. - Agilon has suspended its full-year 2025 financial guidance due to these challenges [7].